Cargando…
Arsenic trioxide as a novel anti-glioma drug: a review
Arsenic trioxide has shown a strong anti-tumor effect with little toxicity when used in the treatment of acute promyelocytic leukemia (APL). An effect on glioma has also been shown. Its mechanisms include regulation of apoptosis and autophagy; promotion of the intracellular production of reactive ox...
Autores principales: | Fang, Yi, Zhang, Zhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517624/ https://www.ncbi.nlm.nih.gov/pubmed/32983240 http://dx.doi.org/10.1186/s11658-020-00236-7 |
Ejemplares similares
-
Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
por: Li, Ning, et al.
Publicado: (2012) -
PML-RARA mutations confer varying arsenic trioxide resistance
por: Bai, Dong-Mei, et al.
Publicado: (2016) -
A Review of Arsenic Trioxide and Acute Promyelocytic Leukemia
por: Alimoghaddam, Kamran
Publicado: (2014) -
Current Advances of Nanomedicines Delivering Arsenic Trioxide for Enhanced Tumor Therapy
por: Yu, Mengzhen, et al.
Publicado: (2022) -
Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide
por: Lin, Tseng-Hsi, et al.
Publicado: (2008)